Related Experiment Video
Updated: Jun 5, 2025
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.5K
Copy number variations of stepwise-selected doxorubicin-resistant MCF-7 cell lines
Hasan Huseyin Kazan1, İrem Sinem Acınan2, Başak Kandemir3
1Department of Medical Biology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.
Gene
|December 5, 2024
Summary
Multidrug resistance (MDR) in breast cancer cells involves complex genetic changes. DNA microarrays reveal significant copy number variations (CNVs) in doxorubicin-resistant MCF-7 cells, highlighting their role in drug resistance.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Multidrug resistance (MDR) is a complex cellular phenotype acquired over time through multiple pathways.
- While gene expression in MDR is studied, segmental and copy number variations (CNVs) are less understood.
- Understanding genetic alterations is crucial for developing effective cancer therapies.
Purpose of the Study:
- To analyze copy number variations (CNVs) in sensitive and doxorubicin-resistant MCF-7 breast cancer cell lines using DNA microarray.
- To investigate the relationship between doxorubicin resistance levels and genomic alterations.
- To identify potential genomic markers associated with multidrug resistance.
Main Methods:
- Conventional karyotyping and array comparative genomic hybridization (aCGH) were performed on sensitive (MCF-7) and two doxorubicin-resistant (MCF-7/400DOX, MCF-7/1000DOX) cell lines.
- aCGH data underwent genomic profiling, comparison analysis, and heterozygosity analysis.
- Gene lists were compared against breast cancer and multidrug resistance-related gene sets.
Main Results:
- Significant differences in CNV profiles and gene copy numbers were observed between the cell lines.
- The number of altered genes was 6212 in MCF-7, 6558 in MCF-7/400DOX, and 11,201 in MCF-7/1000DOX.
- MCF-7/1000DOX exhibited the highest number of altered genes, suggesting a correlation between resistance level and chromosomal changes.
Conclusions:
- Doxorubicin resistance in breast cancer cells is associated with substantial and differential chromosomal changes.
- DNA microarray analysis is a valuable tool for studying cancer drug resistance mechanisms alongside transcriptomic and proteomic approaches.
- Identifying CNVs provides insights into the molecular basis of multidrug resistance, potentially aiding therapeutic strategies.
Related Concept Videos
02:26Comparing Copy Number Variations and SNPs
17.2K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.2K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K